abstract |
A method of purifying recombinant AAV (rAAV) particles from mammalian host cell culture is disclosed. The present disclosure further provides pharmaceutical compositions prepared by the methods of the present disclosure, pharmaceutical compositions for the treatment of diseases, and methods of using the pharmaceutical compositions described herein. |